Clinical Scorecard: Mitochondrial Transfer Between Cells in Melanoma Development and Treatment Resistance: Mechanisms and Therapeutic Implications

At a Glance

Key Highlights

• Intercellular mitochondrial transfer enhances melanoma cell survival and promotes therapeutic resistance.
• Mitochondrial reprogramming is linked to metabolic plasticity in melanoma cells.
• Therapeutic resistance mechanisms include pathway reactivation and immune evasion.
• Mitochondrial transfer can have context-dependent tumor-suppressive effects.
• Understanding mitochondrial dynamics may inform precision treatment strategies.
• Mitochondrial transfer may enhance immune cell function in specific contexts.

Guideline-Based Recommendations

Diagnosis

Management

• Utilize multimodal strategies including surgery, targeted therapy, and immunotherapy.
• Consider therapies that target metabolic pathways and mitochondrial function.

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Targeted therapies may induce mitochondrial biogenesis, increasing OXPHOS dependency, which could affect treatment efficacy.

Clinical Best Practices

• Integrate metabolic modulation with existing targeted and immunotherapeutic approaches.
• Evaluate the role of mitochondrial transfer in patient-specific treatment plans.
• Consider the context-dependent effects of mitochondrial dynamics in therapeutic strategies.
• Monitor mitochondrial dynamics as part of treatment response assessments.

Related Resources & Content

• Mitochondrial Transfer and Melanoma